Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Retina (Philadelphia, Pa.)|December 27, 2018
CORRELATIONS BETWEEN EXPERIMENTAL MYOPIA MODELS AND HUMAN PATHOLOGIC MYOPIAKritchai Vutipongsatorn, Natsuko Nagaoka, Tae Yokoi, et al.
BMC Veterinary Research|December 1, 2021
Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®)Katelin Quantz, Amanda L Anderson, Christine D Harman, et al.
The Journal of Clinical Investigation|December 5, 2017
Patients and animal models of CNGβ1-deficient retinitis pigmentosa support gene augmentation approachSimon M Petersen-Jones, Laurence M Occelli, Paige A Winkler, et al.
EMBO Molecular Medicine|February 22, 2021
Novel AAV capsids for intravitreal gene therapy of photoreceptor disordersMarina Pavlou, Christian Schön, Laurence M Occelli, et al.
International Journal of Molecular Sciences|November 27, 2021
CNGB3 Missense Variant Causes Recessive Achromatopsia in Original Braunvieh CattleIrene M Häfliger, Emma Marchionatti, Michele Stengård, et al.
ESMO Open|March 12, 2021
Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup studyM Guida, S Strippoli, M Maule, et al.
Human Molecular Genetics|November 2, 2021
A large animal model of RDH5-associated retinopathy recapitulates important features of the human phenotypeLaurence M Occelli, Anahita Daruwalla, Samantha R De Silva, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 14, 2023
Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosaLaurence M Occelli, Lena Zobel, Jonathan Stoddard, et al.
Nature Communications|July 15, 2024
A combination treatment based on drug repurposing demonstrates mutation-agnostic efficacy in pre-clinical retinopathy modelsHenri Leinonen, Jianye Zhang, Laurence M Occelli, et al.
The British Journal of Dermatology|April 14, 2020
The prognostic impact of the extent of ulceration in patients with clinical stage I-II melanoma: a multicentre study of the Italian Melanoma Intergroup (IMI)F Portelli, F Galli, L Cattaneo, et al.
Pageof 5